Italia markets closed

QuidelOrtho Corporation (0A55.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
90,83+4,61 (+5,35%)
Alla chiusura: 04:35PM GMT
Schermo intero
Chiusura precedente86,22
Aperto90,47
Denaro0,00 x N/D
Lettera0,00 x N/D
Min-Max giorno90,47 - 90,83
Intervallo di 52 settimane90,47 - 90,83
Volume100
Media VolumeN/D
CapitalizzazioneN/D
Beta (5 anni mensile)0,28
Rapporto PE (ttm)0,04
EPS (ttm)23,62
Prossima data utili15 feb 2023 - 20 feb 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1AN/D
  • GlobeNewswire

    QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022

    SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- QuidelOrtho Corporation (NASDAQ: QDEL) (“QuidelOrtho”), a leading in vitro diagnostics company, today announced it will report financial results for its second quarter 2022 ended July 3, 2022, after the market close on Thursday, August 4, 2022. Following the release of the financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PDT / 5:00 p.m. EDT to discuss the financial results. Interested parties can access the conference

  • GlobeNewswire

    Quidel and Ortho Announce Expected Closing of Ortho Transaction

    SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, and Ortho Clinical Diagnostics Holdings plc (“Ortho”), one of the world’s larger pure-play in vitro diagnostics companies, announced today that the closing of the previously announced Ortho transaction is expected to occur on May 27, 2022. On May 26, 2022, the High Court of Justice of England a

  • GlobeNewswire

    Ortho Clinical Diagnostics Shareholders Approve Quidel Transaction

    RARITAN, N.J., May 16, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho” or the “Company”), one of the world’s largest pure-play in vitro diagnostics (IVD) companies, today announced that based on a preliminary vote count by its proxy solicitor, Ortho shareholders have voted to approve the combination of the Company with Quidel Corporation (NASDAQ: QDEL) (“Quidel”) pursuant to the Business Combination Agreement, dated December 22, 2021, by and among the Com